合計 50 件の最近のインサイダー取引記録が記録されています TFF Pharmaceuticals, Inc. (TFFP), 内訳は 42 件の買い および 4 件の売り. インサイダー買い総額は $823.75K インサイダー売り総額は $684.23K.
最近活動のある主要インサイダーには Rocamboli Stephen, Mills Robert S, King Thomas Braxton. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — TFFP
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2024-07-03 |
Rocamboli Stephen |
Director |
RSU 付与(制限付株式) |
3,165 |
$1.82 |
$5.76K |
3,165 |
| 2024-07-03 |
Mills Robert S |
Director |
RSU 付与(制限付株式) |
3,165 |
$1.82 |
$5.76K |
3,165 |
| 2024-07-03 |
King Thomas Braxton |
Director |
RSU 付与(制限付株式) |
1,583 |
$1.82 |
$2.88K |
1,583 |
| 2024-07-03 |
Roberts Brandi |
Director |
RSU 付与(制限付株式) |
3,165 |
$1.82 |
$5.76K |
3,165 |
| 2024-07-03 |
Lee Catherine Chai-zon |
Director |
RSU 付与(制限付株式) |
1,583 |
$1.82 |
$2.88K |
1,583 |
| 2024-07-03 |
Weisman Harlan F |
President and CEO |
RSU 付与(制限付株式) |
27,480 |
$1.82 |
$50.01K |
27,480 |
| 2024-07-03 |
Coleman Kirk Allen |
Chief Financial Officer |
RSU 付与(制限付株式) |
10,184 |
$1.82 |
$18.53K |
10,184 |
| 2024-07-03 |
Mikhak Zamaneh |
Chief Medical Officer |
RSU 付与(制限付株式) |
10,184 |
$1.82 |
$18.53K |
10,184 |
| 2024-04-18 |
Rocamboli Stephen |
Director |
RSU 付与(制限付株式) |
4,667 |
- |
- |
4,667 |
| 2024-04-18 |
Mills Robert S |
Director |
RSU 付与(制限付株式) |
4,667 |
- |
- |
4,667 |
| 2024-04-18 |
King Thomas Braxton |
Director |
RSU 付与(制限付株式) |
3,110 |
- |
- |
3,110 |
| 2024-04-18 |
Roberts Brandi |
Director |
RSU 付与(制限付株式) |
5,333 |
- |
- |
5,333 |
| 2024-04-18 |
Lee Catherine Chai-zon |
Director |
RSU 付与(制限付株式) |
3,556 |
- |
- |
3,556 |
| 2024-04-18 |
Weisman Harlan F |
President and CEO |
RSU 付与(制限付株式) |
44,967 |
- |
- |
44,967 |
| 2024-04-18 |
Coleman Kirk Allen |
Chief Financial Officer |
RSU 付与(制限付株式) |
5,300 |
- |
- |
5,300 |
| 2024-04-18 |
Mikhak Zamaneh |
Chief Medical Officer |
RSU 付与(制限付株式) |
5,300 |
- |
- |
5,300 |
| 2024-04-18 |
Patane Michael A |
Director |
RSU 付与(制限付株式) |
3,556 |
- |
- |
3,556 |
| 2023-12-13 |
King Thomas Braxton |
Director |
RSU 付与(制限付株式) |
132,442 |
$0.35 |
$46.35K |
132,442 |
| 2023-12-11 |
King Thomas Braxton |
Director |
不明 |
- |
- |
- |
- |
| 2023-12-01 |
Rocamboli Stephen |
Director |
RSU 付与(制限付株式) |
52,858 |
$0.36 |
$19.03K |
52,858 |
| 2023-12-01 |
Mills Robert S |
Director |
RSU 付与(制限付株式) |
52,858 |
$0.36 |
$19.03K |
52,858 |
| 2023-12-01 |
Roberts Brandi |
Director |
RSU 付与(制限付株式) |
52,858 |
$0.36 |
$19.03K |
52,858 |
| 2023-12-01 |
Lee Catherine Chai-zon |
Director |
不明 |
- |
- |
- |
- |
| 2023-12-01 |
Lee Catherine Chai-zon |
Director |
RSU 付与(制限付株式) |
132,442 |
$0.36 |
$47.68K |
132,442 |
| 2023-12-01 |
Patane Michael A |
Director |
不明 |
- |
- |
- |
- |
| 2023-12-01 |
Patane Michael A |
Director |
RSU 付与(制限付株式) |
132,442 |
$0.36 |
$47.68K |
132,442 |
| 2023-08-16 |
Carlson Capital L P |
10 Percent Owner |
情報に基づく売り |
1,000 |
$0.39 |
$391.60 |
5,064,000 |
| 2023-08-15 |
Rocamboli Stephen |
Director |
情報に基づく買い |
20,000 |
$0.25 |
$5K |
36,000 |
| 2023-08-15 |
Mills Robert S |
Director |
情報に基づく買い |
40,000 |
$0.25 |
$10K |
55,980 |
| 2023-08-15 |
Roberts Brandi |
Director |
情報に基づく買い |
20,000 |
$0.25 |
$5K |
20,000 |
| 2023-08-15 |
Weisman Harlan F |
President and CEO |
情報に基づく買い |
600,000 |
$0.25 |
$150K |
814,615 |
| 2023-08-15 |
Coleman Kirk Allen |
Chief Financial Officer |
情報に基づく買い |
20,000 |
$0.25 |
$5K |
35,675 |
| 2023-08-15 |
Mikhak Zamaneh |
Chief Medical Officer |
情報に基づく買い |
120,000 |
$0.25 |
$30K |
135,000 |
| 2023-08-15 |
Carlson Capital L P |
10 Percent Owner |
不明 |
600,000 |
$1.29 |
$774K |
- |
| 2023-08-15 |
Carlson Capital L P |
10 Percent Owner |
情報に基づく売り |
215,000 |
$0.44 |
$94.04K |
5,065,000 |
| 2023-03-22 |
Coleman Kirk Allen |
Chief Financial Officer |
RSU 付与(制限付株式) |
100,000 |
$0.80 |
$80K |
100,000 |
| 2023-03-10 |
Rocamboli Stephen |
Director |
情報に基づく買い |
13,000 |
$0.80 |
$10.43K |
16,000 |
| 2023-03-10 |
Weisman Harlan F |
President and CEO |
情報に基づく買い |
150,000 |
$0.88 |
$131.84K |
214,615 |
| 2023-03-10 |
Coleman Kirk Allen |
Chief Financial Officer |
情報に基づく買い |
12,000 |
$0.79 |
$9.46K |
15,675 |
| 2023-03-10 |
Mikhak Zamaneh |
Chief Medical Officer |
情報に基づく買い |
15,000 |
$0.82 |
$12.3K |
15,000 |
| 2023-01-05 |
Mikhak Zamaneh |
Chief Medical Officer |
処分 |
430,000 |
$0.97 |
$417.1K |
- |
| 2022-12-29 |
Rocamboli Stephen |
Director |
RSU 付与(制限付株式) |
33,475 |
- |
- |
33,475 |
| 2022-12-29 |
Mills Robert S |
Director |
RSU 付与(制限付株式) |
33,475 |
- |
- |
33,475 |
| 2022-12-29 |
Roberts Brandi |
Director |
RSU 付与(制限付株式) |
20,968 |
- |
- |
20,968 |
| 2022-12-29 |
Fletcher Aaron G.l. |
Director |
RSU 付与(制限付株式) |
33,475 |
- |
- |
33,475 |
| 2022-12-15 |
Weisman Harlan F |
President and CEO |
情報に基づく買い |
50,000 |
$1.06 |
$53K |
64,615 |
| 2022-12-03 |
Weisman Harlan F |
President and CEO |
RSU 付与(制限付株式) |
1,792,450 |
- |
- |
1,792,450 |
| 2022-11-22 |
Fletcher Aaron G.l. |
Director |
情報に基づく買い |
21,735 |
- |
- |
21,735 |
| 2022-09-29 |
Thurman Randy H |
Director |
情報に基づく売り |
40,255 |
$4.29 |
$172.69K |
- |
| 2022-05-18 |
Weisman Harlan F |
Director |
情報に基づく買い |
2,500 |
$5.12 |
$12.8K |
10,000 |
■ 情報付き — 公開市場取引(最も重要)
■ 情報なし(買い) — 報酬・オプション行使・転換
■ 情報なし(売り) — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効